How to buy Atomo Diagnostics shares

Atomo Diagnostics Limited is a medical devices business based in Australia. Atomo Diagnostics shares (AT1) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Atomo Diagnostics has a trailing 12-month revenue of around $1.4 million.

How to buy shares in Atomo Diagnostics

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Atomo Diagnostics. Find the share by name or ticker symbol: AT1. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Atomo Diagnostics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $N/A, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Atomo Diagnostics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

Atomo Diagnostics share price

Use our graph to track the performance of AT1 stocks over time.

Atomo Diagnostics shares at a glance

• Key figures

Information last updated 2020-10-10.

52-week range	AUDA$0.285 - AUDA$0.63
50-day moving average	AUDA$0.3251
200-day moving average	AUDA$0.3699
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Atomo Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Atomo Diagnostics Limited by TradingView

Atomo Diagnostics financials

Revenue TTM	$1.4 million
Gross profit TTM	$18,111
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation	$190.8 million

TTM: trailing 12 months

Atomo Diagnostics share dividends

We're not expecting Atomo Diagnostics to pay a dividend over the next 12 months.

Atomo Diagnostics overview

Atomo Diagnostics Limited researches, designs, develops, manufactures, and sells medical devices for blood-based rapid testing for professional use and self-testing. The company offers AtomoRapid RDT platforms to suit various blood-based lateral flow test assays and are appropriate for a range of applications, including screening for chronic conditions and detection of infectious diseases. Its rapid test devices are used by healthcare professionals and by consumers to screen for a range of diseases and medical conditions, including HIV infection. The company has operations in Europe, Asia, Africa, and Central and South America. Atomo Diagnostics Limited was founded in 2010 and is headquartered in Leichhardt, Australia.

Frequently asked questions

• What percentage of Atomo Diagnostics is owned by insiders or institutions?

  Currently 51.473% of Atomo Diagnostics shares are held by insiders and 11.453% by institutions.

• When does the fiscal year end for Atomo Diagnostics?

  Atomo Diagnostics's fiscal year ends in June.

• Where is Atomo Diagnostics based?

  Atomo Diagnostics's address is: Level 2, Leichhardt, NSW, Australia, 2040